3. Segment Information and Concentrations

12 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments: the manufacture and marketing of standard benchtop laboratory equipment for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors and laboratory and pharmacy balances and scales (“Benchtop Laboratory Equipment Operations”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments Operations”) and the design of bioprocessing systems and products and related royalty income (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2014
Revenues	$	4,679,100	$	1,923,300		$	190,800		$	—		$	6,793,200
Foreign Sales		2,617,300		866,900			2,000			—			3,486,200
Income (Loss) from Opertions		156,000		(145,700	)		(49,500	)		(79,500	)		(118,700	)
Assets		4,129,100		1,535,300			799,800			647,600			7,111,800
Long-Lived Asset Expenditures		1,476,500		11,300			8,500			—			1,496,300
Depreciation and Amortization		130,900		35,000			96,900			—			262,800
		Benchtop Laboratory Equipment		Catalyst Research Instruments			Bioprocessing Systems			Corporate and Other			Consolidated
June 30, 2013
Revenues	$	4,466,000	$	2,541,500		$	127,000		$	—		$	7,134,500
Foreign Sales		2,549,100		1,603,800						—			4,152,900
Income (Loss) from Operations		525,900		151,400			(169,900	)		—			507,400
Assets		2,501,600		1,646,600			903,600			1,101,200			6,153,000
Long-Lived Asset Expenditures		18,300		23,300			9,200			—			50,800
Depreciation and Amortization		43,300		35,300			100,200			—			178,800